Orthofix International | OFIX - Beneficio Bruto En Ventas

Precio De Mercado
11.83
Cambio Diario
0.18 1.55%
Mensual
-7.22%
Anual
-29.33%
Q1 Expectativa
11.30




Beneficio Bruto En Ventas Cambio Fecha
Accuray USD 41.89M 7.42M 2024-12
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 105.34M 4M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
EDAP TMS EUR 5.97M 850K 2025-09
Globus Medical USD 535.95M 49.28M 2025-12
Hologic USD 586.4M 2.9M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
J&J USD 16.6B 118M 2025-12
Medtronic USD 5.41B 27M 2025-12
Mesa Laboratories USD 39.75M 4.3M 2024-12
Orthofix International USD 153.28M 4.76M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Stryker USD 4.49B 633M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Veracyte USD 101.97M 10.69M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12